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Background: UK Biobank is a large prospective cohort study containing accelerometer-based physical activity data
with strong validity collected from 100,000 participants approximately 5 years after baseline. In contrast, the main
cohort has multiple self-reported physical behaviours from > 500,000 participants with longer follow-up time,
offering several epidemiological advantages. However, questionnaire methods typically suffer from greater
measurement error, and at present there is no tested method for combining these diverse self-reported data to
more comprehensively assess the overall dose of physical activity. This study aimed to use the accelerometry sub-
cohort to calibrate the self-reported behavioural variables to produce a harmonised estimate of physical activity
energy expenditure, and subsequently examine its reliability, validity, and associations with disease outcomes.
Methods: We calibrated 14 self-reported behavioural variables from the UK Biobank main cohort using the wrist
accelerometry sub-cohort (n = 93,425), and used published equations to estimate physical activity energy
expenditure (PAEESR). For comparison, we estimated physical activity based on the scoring criteria of the
International Physical Activity Questionnaire, and by summing variables for occupational and leisure-time physical
activity with no calibration. Test-retest reliability was assessed using data from the UK Biobank repeat assessment
(n = 18,905) collected a mean of 4.3 years after baseline. Validity was assessed in an independent validation study
(n = 98) with estimates based on doubly labelled water (PAEEDLW). In the main UK Biobank cohort (n = 374,352),
Cox regression was used to estimate associations between PAEESR and fatal and non-fatal outcomes including all-
cause, cardiovascular diseases, respiratory diseases, and cancers.
Results: PAEESR explained 27% variance in gold-standard PAEEDLW estimates, with no mean bias. However, error
was strongly correlated with PAEEDLW (r = −.98; p < 0.001), and PAEESR had narrower range than the criterion. Test-
retest reliability (Λ = .67) and relative validity (Spearman = .52) of PAEESR outperformed two common approaches for
processing self-report data with no calibration. Predictive validity was demonstrated by associations with morbidity
and mortality, e.g. 14% (95%CI: 11–17%) lower mortality for individuals meeting lower physical activity guidelines.
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Conclusions: The PAEESR variable has good reliability and validity for ranking individuals, with no mean bias but
correlated error at individual-level. PAEESR outperformed uncalibrated estimates and showed stronger inverse
associations with disease outcomes.
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Higher levels of physical activity have been shown to be
associated with a lower risk of morbidity and mortality
[1], but accurately assessing the dose of physical activity
in large population studies remains challenging. Most
large cohort studies with long follow-up have utilised
self-report questionnaires to assess physical activity.
These methods typically have lower cost and higher
feasibility than more objective methods but are prone to
measurement error [2], and may not capture physical ac-
tivity across all activity domains meaning the full dose is
not characterised [3]. UK Biobank has shown that it is
feasible to collect accelerometer-based physical activity
data with strong validity [4] on a large scale (n > 100,
000) [5]. Despite this, the main UK Biobank cohort is
five times larger and has longer follow-up time to mor-
bidity and mortality outcomes, which offers several epi-
demiological advantages compared to the more recent
accelerometer sub-cohort. However, there is currently
no tested method for estimating total volume of physical
activity from the self-report information in UK Biobank
collected at baseline.
The baseline questionnaire includes items adapted
from the International Physical Activity Questionnaire
(IPAQ) [6] and the Recent Physical Activity Question-
naire (RPAQ) [7, 8]. Responses could theoretically be
processed separately using methods developed specific-
ally for those two questionnaires, but using the totality
of the available data should provide a more comprehen-
sive estimate of the total dose, as they capture informa-
tion about complimentary types, intensities and domains
of activity. Previous work has shown how these self-
reported behaviours relate to a summary of movement
volume from 24-h wrist acceleration [9], and how wrist
acceleration relates to physical activity energy expend-
iture (PAEE) as measured by the gold-standard method
of doubly labelled water [4]. Despite the paucity of valid-
ation studies describing the direct relationship between
these self-report data and those from the gold-standard
method, it is possible to use network harmonisation [10]
to combine the above strands of evidence to estimate
PAEE; this would capitalise on the very large sample size
of strand one and the more robust relationship between
two objective measures in strand two, but the reliability
and validity of this approach have not yet been tested in
this context.This study aimed to: 1) use the UK Biobank accelero-
metry sub-cohort to harmonise the self-reported behav-
ioural variables and produce a summary estimate of
PAEE; 2) examine test-retest reliability of this estimate
using the UK Biobank repeat assessment sub-cohort; 3)
assess validity of the PAEE estimate using values from a
gold-standard doubly labelled water (DLW) based as-
sessment in an independent validation study; 4) investi-
gate associations of the PAEE estimate with morbidity
and mortality in the main UK Biobank cohort.
Methods
The following sections set out the collection and pro-
cessing of relevant data in UK Biobank, the methods of
the DLW validation study, and the statistical analyses.
UK Biobank
Participants and study design
UK Biobank is an ongoing prospective cohort study of
502,625 adults aged 40–69 years residing within 25miles
of one of 22 assessment centres in England, Scotland,
and Wales. Additional file 1: Figure S1 describes the ex-
clusion criteria and sample sizes used in different com-
ponents of the present study. Participants were
identified from National Health Service general practi-
tioner registries and invited to a baseline assessment be-
tween 2006 and 2010 [11]. A subsample of 20,346
participants attended a repeat assessment visit (2012–
2013), and between 2013 and 2015 another partially
overlapping subsample of 106,053 participated in a
follow-up study during which they wore a wrist-
mounted accelerometer for 7 days [5]. The UK Biobank
study was approved by the North West Multicentre Re-
search Ethics Committee and all participants provided
written informed consent. Data for the current analysis
were downloaded on 4th April 2019, containing infor-
mation from 502,536 participants with baseline measures
following withdrawals.
Self-reported behaviours
Physical activity, television viewing, computer use, and
sleep were self-reported using a touch-screen question-
naire and responses were used to generate behavioural
variables as previously described [9]. There are a total of
14 behavioural variables which are detailed in
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baseline (2006–2010) and in a subsample during the
repeat-assessment visit (2012–2013). IPAQ-based ques-
tions were used to derive minutes per day of moderate-
to-vigorous physical activity (MVPA), as well as the
IPAQ score in metabolic equivalent of task (MET) mi-
nutes/day for comparison [6] (Supplementary Table S2).
Similarly, RPAQ-based questions were used to derive
(minutes per day unless stated otherwise): walking for
pleasure, strenuous sports, other exercises, light do-it-
yourself (DIY), heavy DIY, heavy physical work, walking/
standing work, sedentary work, getting about method
(categorical: car or public transport, mixed use, walking
or cycling), commuting method (categorical: car or pub-
lic transport, mixed use, walking or cycling), television
viewing (hours per day), computer use (hours per day).
The questions are similar but not identical to those used
in the original RPAQ [7]. Therefore, an alternative sum-
mary was computed for this instrument following the
same scoring principles; this score in MET-minutes/day
comprised the sum of leisure-time and occupational
physical activity and is denoted LTPA+OPA in the
present analysis (Supplementary Table S2). Sleep and
nap time was categorised as: ≤ 5 h per day, 6 h per day,
7 h per day, 8 h per day, ≥ 9 h per day. As part of pilot
testing, some participants completed a different baseline
questionnaire to the rest of the main cohort; the data
were incompatible and we therefore excluded these par-
ticipants (n = 3797). We also removed participants for
whom the sum of daily MVPA, television viewing, com-
puter use and sleep was greater than 24 h (n = 4514).
These variables were chosen as they should be mutually
exclusive and thus used to detect generic misunder-
standing of the behavioural questions.
Accelerometer sub-cohort
The collection and processing of the accelerometer data
have been described in greater detail previously [5]. Be-
tween 2013 and 2015 invitations to participate in the ac-
celerometer sub-cohort were sent to 236,519
participants who had provided a valid email address at
recruitment. Consenting participants (n = 106,053) were
sent an accelerometer (Axivity AX3, Newcastle upon
Tyne, UK) initialised to capture three-dimensional accel-
eration at 100 Hz continuously for 7 days which they
were asked to begin wearing immediately on their dom-
inant wrist. Participants were asked to return the accel-
erometer via pre-paid envelope after the monitoring
period. Euclidean norm minus one (ENMO) was calcu-
lated as the Euclidean norm (vector magnitude) of cali-
brated acceleration [12] in three axes minus one
gravitational unit (1000 m-g) and negative values were
truncated to zero [13]. Periods of ≥ 60 min during which
the standard deviations (SD) of all three axes were <13.0 m-g were identified as non-wear. Mean wrist
ENMO in m-g was summarised across valid wear-time
(data across the full 24 h spectrum and at least 72 h of
wear in total) for each individual whilst minimising diur-
nal bias caused by non-wear [14].
Calibration models
In order to utilise the totality of the self-report informa-
tion in UK Biobank, linear regression models were fitted
to estimate the association between the 14 behavioural
variables and movement volume (ENMO) using data
from the accelerometry sub-cohort. Continuous self-
report variables were natural log (loge(x + 1)) trans-
formed (+ 1 due to zero values). Coefficients were mutu-
ally adjusted (i.e. entered in the same regression model)
and derived separately for men and women. We also
accounted for change in both age and season between
baseline and the accelerometry assessment by adding
delta terms to the regression models. Participants with
< 72 h of wear time (n = 6310) or mean wrist ENMO ≥
500 m-g (n = 4) were excluded. The standard error (SE)
of each predicted PAEE was calculated using the
variance-covariance matrix from the model and the
values of each variable.
Prediction of PAEE from self-report (PAEESR)
The sex-specific regression models developed in the
accelerometry sub-cohort were used to predict mean
wrist ENMO from self-report data in the main UK Bio-
bank cohort. These predicted wrist ENMO values were
then converted to PAEESR in kJ/day/kg using data from
a similarly aged UK cohort [15] and a previously re-
ported scaling equation for dominant wrist acceleration
[4]. To assess reliability, this process was repeated for
participants with complete self-report data collected
during the repeat assessment visit (n = 18,905).
To propagate the uncertainty of the initial prediction
of wrist ENMO and subsequent conversion to PAEESR,
predicted wrist ENMO values were resampled 100 times
at random from normal distributions centered at each
individual’s estimated wrist ENMO and its SE. In the
same way, we sampled 100 beta and alpha coefficients
used to convert wrist ENMO to PAEESR. Wrist ENMO
was then converted to PAEESR using the 100 sets of
sampled values and coefficients. The mean and SD of
the 100 predictions for each individual were used as the
point estimate of PAEESR and its SE, respectively.
Outcome assessment for survival analyses
Vital status and primary or secondary diagnoses of hos-
pital episodes of participants were established by linkage
to national death registry data obtained from the Health
and Social Care Information Centre for England and
Wales and the Information Services Department for
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in England and Wales, and 30th November 2016 in
Scotland. International Classification of Diseases 10th
edition codes were used to define disease outcomes as
shown in Supplementary Table S3. Non-fatal outcomes
were hospital episodes of heart failure, stroke, ischaemic
heart disease, atrial fibrillation, all cardiovascular disease,
chronic obstructive pulmonary disease, all respiratory
disease, cancers including breast, prostate, endometrial,
lung, colon, oesophageal, liver, gastric cardia, myeloid
leukaemia, myeloma, rectum, bladder, malignant melan-
oma, and all cancer. Selection of site-specific cancer out-
comes was based upon a previous review [16] and at
least 25 events in the follow-up period. Fatal outcomes
were all-cause mortality, cardiovascular disease mortal-
ity, respiratory disease mortality, and cancer mortality.
Covariate assessment for survival analyses
Demographic, lifestyle, and clinical variables were
assessed at baseline by the aforementioned touch-screen
questionnaire, verbal interview, or physical measure-
ment. The following variables were considered as poten-
tial confounders of the relationship between PAEESR and
all-cause mortality: age, sex, ethnicity (white/non-white),
Townsend deprivation index, highest educational level
(degree or above/any other qualification/no qualifica-
tion), employment status (unemployed/in paid or self-
employment), alcohol consumption (never/previous/
current), smoking (never/previous/current), salt added
to food (never/sometimes), oily fish intake (never/some-
times), fruit and vegetable intake (score from 0 to 4),
processed and red meat intake (average weekly fre-
quency in days per week), body mass index (BMI) in
three categories (< 25, 25–30, ≥ 30 kg•m− 2), parental
cancer history including history of bowel, lung, maternal
breast cancer, or paternal prostate cancer (yes/no), par-
ental history of heart disease, stroke, hypertension or
diabetes (yes/no), use of blood pressure medication (yes/
no), use of cholesterol lowering medication (yes/no),
doctor-diagnosed diabetes or treatment with insulin
(yes/no), doctor-diagnosed coronary heart disease, stroke
or cancer (yes/no).
DLW validation study
The validity of PAEESR values was assessed using DLW-
based PAEE values (PAEEDLW) in an independent valid-
ation study, details of which have previously been re-
ported [4]. Participants were 100 adults aged 40–70
years recruited from the Fenland Study [17, 18] and in-
vited to two assessment visits separated by 9–14 days for
gold-standard assessment of total energy expenditure
[19–30]. Resting energy expenditure and diet-induced
thermogenesis values were subtracted from total energy
expenditure and divided by body mass yielding anestimate of total daily PAEEDLW in kJ/day/kg. Partici-
pants also answered the UK Biobank questions needed
to generate PAEESR using the calibration model de-
scribed above, although data were incomplete for some
(n = 2). Ethical approval for this study was obtained from
Cambridge University Human Biology Research Ethics
Committee (Ref: HBREC/2015.16). All participants pro-
vided written informed consent.
Statistical analyses
Test-retest reliability of behavioural variables, PAEESR, IPAQ,
and LTPA+OPA
Test-retest reliability (repeatability) of the 14 behavioural
variables as well as the PAEESR, IPAQ, and LTPA+OPA
summary scores was examined by regression of the re-
peat assessment measures (2012–2013) on baseline mea-
sures (2006–2010) yielding lambda coefficients [31] and
their standard errors, while (weighted) Cohen’s kappa
coefficients [32] were calculated for ordinal variables.
Validity of PAEESR, IPAQ, and LTPA+OPA
Absolute validity (agreement) of the PAEESR values was
assessed by calculating the mean bias and 95% limits of
agreement [33] compared with PAEEDLW. We used
PAEEDLW as the criterion in the main analysis rather than
the average between PAEESR and PAEEDLW, which has
been recommended [34]. However, error in PAEEDLW is
very low compared to self-report, meaning PAEEDLW is
likely to be closer to the latent ‘true’ level of the exposure.
The plot of PAEESR vs the average of PAEESR and
PAEEDLW was conducted as a sensitivity analysis. Precision
was assessed by calculating root mean square error (RMSE),
i.e. the square-root of the mean squared differences. Indi-
vidual differences between PAEESR and PAEEDLW were ex-
amined visually across the measurement range of the
criterion. The association between each of PAEESR, IPAQ,
and LTPA+OPA with PAEEDLW was modelled using lin-
ear regression. The relative validity (similar ranking of indi-
viduals) of the three summary scores was examined with
Spearman’s rank-order correlation using PAEEDLW.
Survival analyses
In the main UK Biobank cohort, Cox regression with age
as the underlying timescale was used to estimate associa-
tions between PAEESR and each of the fatal and non-fatal
outcomes, adjusted for all covariates listed above, and in a
separate model omitting BMI. Hazard ratios were pre-
sented per 5 kJ/day/kg of PAEE as this is approximately
equivalent to the lower World Health Organization guide-
line of 150min of moderate intensity activity per week
[35]. Models were weighted using the inverse of the
individual-level SE; weights were normalised such that the
sum of weights equalled the analytical sample size. Indi-
viduals with missing exposure data (n = 20,133) or
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analyses, as were individuals with pre-baseline hospital ep-
isodes of ischaemic heart disease, stroke, respiratory dis-
ease or cancer as defined above (n = 55,574), and those
with only self-reported doctor-diagnosed ischaemic heart
disease, stroke, or cancer (n = 23,402). Finally, we excluded
participants experiencing events in the first 2 years of
follow-up (n = 986 for mortality; range 22 to 24,084 for
non-fatal outcomes), meaning the final analysis sample for
mortality analyses included 374,352 participants, with
fewer for analyses of non-fatal outcomes. Breast and pros-
tate cancer analyses were conducted in women only and
men only, respectively.
For fatal outcomes, we compared the associations of
each of the three summary scores (PAEESR, IPAQ, and
LTPA+OPA) using the modelling approach described
above, and presented hazard ratios per 1 SD increment
of each exposure. We also repeated this adding sleep as
a covariate in the Cox regression model when using
IPAQ and LTPA+OPA. In sensitivity analyses, hazard
ratios were also estimated by quartile of PAEESR using
all covariates, and in a separate model omitting BMI.
We also replicated the main analysis described above in
only those participants reporting pre-baseline disease
and who did not die within 2 years of follow-up (n = 77,
843). In addition, the associations between PAEESR and
each of the disease outcomes were assessed using cubic
spline regression models (3 knots) using all the covari-
ates. For this analysis, we used a reference PAEESR level
of a hypothetical man or woman reporting: no leisure-
time physical activity, 8 hours per day of sedentary occu-
pation, 2 hours per day of television viewing, 2 hours per
day of computer use, motorised transport for commut-
ing and getting about, and sleeping for ≥ 9 h per day. All
analyses were conducted using STATA/SE 14.2 (Stata-
Corp, TX, USA).
Results
Baseline characteristics of participants from the studies
included in analyses are shown in Table 1. Participants
in the DLW validation study were, on average, 2 years
younger and more active than those in UK Biobank. Fol-
lowing exclusions, 52,507 women and 41,918 men were
included in the two separate regression analyses to pre-
dict wrist movement from self-report data. The resulting
models explained 14 and 17% of variance in mean wrist
ENMO (m-g) in women and men respectively. The sex-
specific coefficients for the 14 behavioural variables are
shown in Additional file 1: Table S4.
Test-retest reliability of behavioural variables, PAEESR,
IPAQ, and LTPA+OPA scores
The mean (SD) time between baseline (2006–2010) and
repeat assessment (2012–2013) was 4.3 (0.9) years.Table 2 summarises self-reported behaviours at both
time points: the largest change in reported behaviours
between baseline and repeat assessment was for occupa-
tional variables, all of which decreased in duration. Test-
retest reliability was higher for PAEESR than for the
IPAQ or LTPA+OPA scores of MET-minutes per day.
Validity of PAEESR, IPAQ, and LTPA+OPA scores
Self-report data were complete for 98 out of 100 partici-
pants in the DLW validation study. Figure 1 shows
PAEESR minus PAEEDLW plotted against PAEEDLW.
PAEEDLW mean (SD) was 50.0 (16.1) kJ/day/kg com-
pared with 48.9 (3.7) kJ/day/kg for PAEESR. The mean
bias was − 1.1 (95%CI: − 4.0 to 1.8 kJ/day/kg), or − 2% of
the criterion mean, and the limits of agreement were −
30.2 to 28.1 kJ/day/kg (±58%). The RMSE was 14.5 kJ/
day/kg, or 29% of the criterion mean. Error of PAEESR
was strongly correlated with PAEEDLW (r = −.98; p <
0.001); PAEESR was an overestimate for less active indi-
viduals and an underestimate for the more active. Plot-
ting error of PAEESR vs the average of PAEESR and
PAEEDLW showed a similar proportional bias (r = −.93;
p < 0.001, Supplemental Fig. S2). The range of PAEESR
(40.5 to 56.2 kJ/day/kg) was 81% narrower than
PAEEDLW (9 to 91 kJ/day/kg). Spearman correlation be-
tween PAEESR and PAEEDLW was rs = .52 (p < 0.001),
while for IPAQ and LTPA+OPA, Spearman correlations
with PAEEDLW were rs = .23 (p = 0.022) and rs = .41 (p <
0.001), respectively. PAEESR explained 27% of variance
in PAEEDLW with a large negative intercept (Fig. 1). By
comparison, IPAQ and LTPA+OPA scores explained 5
and 8%, respectively.
Survival analyses
During a median (interquartile range) 8.9 (8.3–9.5) years
of follow-up (3,311,773 person-years), 9372 participants
died. Each 5 kJ/day/kg of PAEESR (equivalent to meeting
the lower activity recommendations) was associated with
an approximate 14% lower hazard of all-cause mortality
(Fig. 2). Incidence of non-fatal respiratory disease (but
severe enough to require hospital admission) was more
strongly associated with PAEESR than non-fatal cardio-
vascular disease or cancer incidence. Amongst site-
specific cancers, PAEESR was only associated with non-
fatal breast and kidney cancers; numbers of people with
most site-specific cancers were small. Similar associa-
tions were observed when omitting BMI as a covariate
(Additional file 1: Figure S4), but associations were gen-
erally stronger in those with pre-baseline disease than
the main cohort (Additional file 1: Figure S5; character-
istics presented in Table S6). Comparing mortality asso-
ciations of the three summary scores, hazard ratios for
mortality per 1 SD increment were consistently strongest
for PAEESR (Fig. 3). The IPAQ and LTPA+OPA scores
Table 1 Characteristics of participants in UK Biobank and the DLW validation study
UK Biobank Independent DLW
validation studyMain cohort Accelerometer sub-cohort
Analysis sample (n) 374,352 93,425 98
Age at baseline (years) 56 (8) 56 (8) 54 (7)
Age at postal follow-up (years) – 62 (8) –
Proportion of women 56% 56% 50%
Weight (kg) 78 (16) 77 (15) 77 (14)
Body mass index (kg/m2) 27 (5) 27 (5) 27 (3)
Minutes per day of:
Heavy physical work 21 (51) 16 (43) 38 (65)
Walking/standing work 56 (91) 48 (84) 91 (107)
Sedentary work 110 (143) 122 (146) 144 (153)
MVPA 90 (110) 85 (99) 124 (125)
Walking for pleasure 14 (22) 15 (22) 16 (27)
Strenuous sports 2 (10) 3 (10) 4 (12)
Other exercises 9 (17) 10 (17) 12 (16)
Light DIY 10 (24) 11 (24) 11 (28)
Heavy DIY 6 (19) 6 (18) 7 (24)
Hours per day of:
Television viewing 3 (2) 2 (1) 2 (1)
Computer use 1 (1) 1 (1) 2 (2)
Getting about method:
Car or public transportation 48% 44% 41%
Mixed use 43% 47% 32%
Walking or cycling 9% 9% 27%
Commuting method:
Car or public transportation 87% 85% 59%
Mixed use 8% 10% 19%
Walking or cycling 5% 5% 22%
Hours per day of sleep:
≤ 5.0 5% 4% 0%
6.0 19% 18% 4%
7.0 40% 43% 32%
8.0 29% 29% 49%
≥ 9.0 7% 6% 15%
PAEESR (kJ/day/kg) 47 (4) 48 (4) 49 (4)
IPAQ scoring (MET-minutes/day) 373 (458) 357 (412) 509 (468)
LTPA+OPA scoring (MET-minutes/day) 380 (425) 349 (383) 572 (560)
DIY do-it-yourself, DLW doubly labelled water, IPAQ International Physical Activity Questionnaire, LTPA+OPA leisure-time and occupational physical activity, MET
metabolic equivalent of task, MVPA Moderate-to-vigorous physical activity, PAEESR physical activity energy expenditure predicted from self-report
Values are means (standard deviations) unless otherwise stated
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to PAEESR. Additionally adjusting for sleep in the Cox
model did not meaningfully alter associations for IPAQ
and LTPA+OPA scores (data not shown).There were dose-response associations across quartiles
of PAEESR, with lower hazard in higher quartiles, and at-
tenuation of the effect with additional adjustment for
BMI (Supplementary Table S5). There was a non-linear
Table 2 Reliability of self-reported behaviours using baseline and repeat assessment in UK Biobank (n = 18,905)
Baseline Repeat Lambda/kappa (SE)
Years between baseline and repeat:
< 3 11%
≥ 3 to < 4 24%
≥ 4 to < 5 43%
≥ 5 to < 6 21%
≥ 6 1%
Minutes per day of:
Heavy physical work 16 (43) 11 (36) Λ = 0.527 (0.005)
Walking/standing work 47 (82) 31 (70) Λ = 0.482 (0.005)
Sedentary work 112 (143) 76 (128) Λ = 0.609 (0.005)
MVPA 83 (99) 81 (94) Λ = 0.479 (0.006)
Walking for pleasure 15 (22) 16 (24) Λ = 0.520 (0.007)
Strenuous sports 3 (10) 2 (10) Λ = 0.453 (0.006)
Other exercises 10 (18) 10 (17) Λ = 0.456 (0.006)
Light DIY 11 (26) 10 (23) Λ = 0.256 (0.006)
Heavy DIY 7 (19) 6 (17) Λ = 0.273 (0.006)
Hours per day of:
Television viewing 3 (1) 3 (2) Λ = 0.821 (0.005)
Computer use 1 (1) 1 (1) Λ = 0.547 (0.007)
Getting about method: Κ = 0.324 (0.006)
Car or public transportation 49% 48%
Mixed use 44% 45%
Walking or cycling 7% 7%
Commuting method: Κ = 0.487 (0.006)
Car or public transportation 90% 93%
Mixed use 7% 5%
Walking or cycling 3% 2%
Hours per day of sleep: Κ = 0.500 (0.005)
≤ 5.0 3% 4%
6.0 18% 17%
7.0 42% 40%
8.0 30% 31%
≥ 9.0 7% 8%
PAEESR (kJ/day/kg) 46 (4) 47 (4) Λ = 0.671 (0.005)
IPAQ scoring (MET-minutes/day) 345 (411) 342 (395) Λ = 0.489 (0.006)
LTPA+OPA scoring (MET-minutes/day) 349 (382) 281 (337) Λ = 0.552 (0.005)
DIY do-it-yourself, IPAQ International Physical Activity Questionnaire, LTPA+OPA leisure-time and occupational physical activity, MET metabolic equivalent of task,
MVPA moderate-to-vigorous physical activity, PAEESR physical activity energy expenditure predicted from self-report, SE standard error, Λ Lambda coefficient, Κ
weighted kappa coefficient
Values are mean (standard deviation) unless otherwise stated
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(Supplementary Fig. S3), with steeper gradient of the re-
lationship moving from the least active individual to ~
15 kJ/day/kg PAEESR, and shallower gradient above that
level with greater uncertainty.Discussion
This study reports the reliability and validity of PAEE
predicted from a range of self-reported behaviours using
a network harmonisation approach which included cali-
bration to 7-day wrist accelerometry in approximately
Fig. 1 Validity of physical activity energy expenditure predicted from self-report (PAEESR) vs. doubly labelled water based PAEE (PAEEDLW). Upper
panel shows scatter plot with line of unity (dashed) and regression line (solid); lower panel shows differences between physical activity energy
expenditure predicted from self-report (PAEESR) and PAEEDLW, plotted against PAEEDLW. Reference lines indicate mean difference (dotted) and
95% limits of agreement (dashed). n = 98
Pearce et al. International Journal of Behavioral Nutrition and Physical Activity           (2020) 17:40 Page 8 of 13100,000 free-living individuals. Our findings suggest that
this method of combining behavioural data in UK Bio-
bank produces PAEE values suitable for ranking individ-
uals (based on Spearman’s rank-order correlation) and
demonstrates predictive validity when examining associ-
ations with morbidity and mortality, for example show-
ing 14% lower mortality for individuals accumulating
PAEE equivalent to meeting the lower World Health
Organization physical activity guidelines [35]. However
there are challenges with interpretation on an absolute
scale due to marked under- and over-estimation at the
exposure extremes.Test-retest reliability of PAEESR outperformed
MET-minute scores from IPAQ and LTPA+OPA and
many previous self-reported estimates [2] despite an
average of 4 years between baseline and repeat assess-
ment, during which it might be expected for physical
activity to decline in this population. We were not
able to examine whether there were ‘true’ within-
individual changes in PAEE between time-points
using a criterion, but accounting for such changes
would likely serve to improve reliability coefficients
observed here. It is encouraging to note that although
the behaviours demonstrated relatively poor test-retest
Fig. 2 Hazard ratio (HR) and 95% confidence interval (CI) for linear associations of physical activity energy expenditure predicted from self-report
(PAEESR, per 5 kJ/day/kg increments) with fatal and non-fatal outcomes in UK Biobank. Event-rate per 100,000 person years. Adjusted for age (as
timescale), sex, ethnicity, Townsend deprivation index (baseline hazard stratification), highest educational level, employment status, alcohol
drinking status (baseline hazard stratification), smoking status, salt added to food, oily fish intake, fruit and vegetable intake, processed and red
meat intake, body mass index, parental history of cancer, parental history of [heart disease, stroke, hypertension or diabetes], use of blood
pressure medication, use of cholesterol lowering medication, doctor-diagnosed diabetes or treatment with insulin. COPD chronic obstructive
pulmonary disease; CVD cardiovascular disease; IHD ischaemic heart disease. *COPD incidence likely only represents the most severe cases as
only approximately 25% of COPD cases are picked up in Hospital Episode Statistics data, compared to national surveys [36]
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estimate of PAEESR which seems to better reflect a
habitual level of activity.
In the separate DLW validation study, PAEESR showed a
non-significant 2% underestimation and explained 27%
variance in PAEEDLW. This compares favourably to the
relative validity of scores from IPAQ and LTPA+OPA re-
ported here, as well as self-reported activity volume in pre-
vious work [2], with stronger criterion validity than
estimates from IPAQ [6, 37, 38] and RPAQ [7, 8], on whichthe questions are based. This may be explained by inclusion
of a more comprehensive and complimentary list of phys-
ical activity behaviours, as well as sleep and sedentary be-
haviours which also provide information about the total
volume of movement each day. Our validation study find-
ings indicate that PAEESR explains much higher levels of
variance in the ‘true’ volume of physical activity assessed by
PAEEDLW, and this is reflected in stronger associations with
mortality in UK Biobank compared with IPAQ and
LTPA+OPA, which were more attenuated.
Fig. 3 Hazard ratio (HR) and 95% confidence interval (CI) for linear associations between physical activity volume and mortality in UK Biobank.
Physical activity volume is derived using three assessment methods: physical activity energy expenditure predicted from self-report (PAEESR),
International Physical Activity Questionnaire (IPAQ) scoring of MET-minutes/day, and sum of leisure-time physical activity and occupational
physical activity MET-minutes/day (LTPA+OPA). All HRs per 1 standard deviation increment of exposure. Event-rate per 100,000 person years.
Adjusted for age (as timescale), sex, ethnicity, Townsend deprivation index (baseline hazard stratification), highest educational level, employment
status, alcohol drinking status (baseline hazard stratification), smoking status, salt added to food, oily fish intake, fruit and vegetable intake,
processed and red meat intake, body mass index, parental history of cancer, parental history of [heart disease, stroke, hypertension or diabetes],
use of blood pressure medication, use of cholesterol lowering medication, doctor-diagnosed diabetes or treatment with insulin.
CVD cardiovascular disease, MET metabolic equivalent of task
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with the criterion PAEEDLW, i.e. displaying regression to
the mean which is a consequence of using a relatively
weak self-report instrument and prediction equations
explaining relatively low levels of variance in wrist ENMO.
The explanatory power of our models could have been
strengthened using additional predictors (e.g. age, adipos-
ity, etc.), but these are not directly representative of activ-
ity, and inclusion of more complicated predictors could
hinder the transferability of newly derived models even if
the relevant behavioural variables are available. Therefore,
in order to make results more useful in answering epi-
demiological questions about the role of physical activity,
we employed a model using behavioural data. Weak pre-
diction models with a large constant narrowed theobserved range of predicted values substantially resulting
in overestimation at the lower end and underestimation
for more active individuals, widening the 95% limits of
agreement. The component of PAEESR from the constant
is mathematically insensitive to differences in behaviour
between individuals and does not influence correlations
with criterion PAEEDLW or health associations; it does,
however, impact interpretation of the exposure on an ab-
solute scale, which presents a challenge for translation of
observed associations with mortality to public health rec-
ommendations [39]. To facilitate such interpretation, we
marginalised PAEESR by subtracting the level of exposure
of the least active individual from all participants in the
analytical sample. The resulting dose-response curve for
all-cause mortality is consistent with messages
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lower end of the exposure range [40]. Future work should
explore methods to remedy these prediction errors and
make use of alterative statistical approaches which com-
bine data to give an integrated score [41]; the present
study aimed to predict physical activity volume rather
than characterise the overall pattern of health-related
behaviours.
Limitations of this study include a healthy volunteer se-
lection bias in UK Biobank such that it is not representa-
tive of the general population [42]; the accelerometer sub-
cohort may also suffer from selection bias, although no
major differences in self-reported behaviours or PAEESR
were observed here. There was an average 5.7 year gap be-
tween baseline self-reported behaviours and the acceler-
ometer data used for calibration. We cannot rule out that
physical activity may have changed in this time, although
PAEESR in the repeat assessment sub-cohort was relatively
stable over a similar period and we accounted for change
in age and season between these time points when deriv-
ing the prediction equations. The generalisability of pre-
diction equations to those who did not survive until the
accelerometry sub-cohort commenced must also be con-
sidered. This would be a concern if individuals who died
during this period exhibited different relationships be-
tween self-reported behaviours and wrist ENMO, rather
than just different behaviours. Given the size of the cali-
bration samples, we argue that the heterogeneity of rela-
tionships included when deriving the models is sufficient.
Furthermore, the accelerometry sub-study occurred over a
number of years, meaning that some individuals who died
relatively early in the follow-up period would have been
included. Further work is necessary to explore the effects
of using calibration equations with relatively weak self-
report instruments, as these will be important for future
harmonisation efforts (e.g. for synthesis of data from stud-
ies using different self-report methods). In particular, it is
necessary to understand how calibrated and non-
calibrated self-reported data should be used to estimate
associations with disease outcomes across the full dose
range, given the challenges of interpretation we have re-
ported. Strengths of the work include use of PAEEDLW for
examining validity, and propagation of the uncertainty
(prediction errors) accrued at each step of our method for
estimating PAEE to the analyses of associations with dis-
ease outcomes. Wrist accelerometry has strong validity
compared to PAEEDLW [4], but is not available in the
whole UK Biobank cohort and there is much less follow-
up time in the sub-cohort where the measure is available.
We used a robust criterion to calibrate and harmonise 14
self-report variables, with the added advantage that the ne-
cessary self-report data exist for approximately 475,000
participants, permitting use as an exposure, outcome, or
covariate in future analyses.Conclusions
In conclusion, we have successfully utilised a network har-
monisation approach to exploit the diverse behavioural
data in UK Biobank and derive an overall summary esti-
mate of PAEE. The PAEESR variable has good reliability
and validity for ranking individuals compared with other
self-report methods. It is the only estimate of PAEE avail-
able in the main UK Biobank cohort which has been
tested against the gold-standard DLW-based criterion,
showing no mean bias but a systematic bias at individual
level stemming from inherent weaknesses of the self-
report data. It does however have predictive validity in
that it is prospectively associated with morbidity and mor-
tality, and in a way that can be interpreted in a public
health framework.
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